Sevan Habeshian & Christian Heinis et al. https://www.nature.com/articles/s41467-022-31428-Drug DesignMacrocycles: big is the new beautifulIn the evolving landscape of drug discovery and new design, scientists and pharmaceutical innovators continually strive to develop therapies that are both highly selective and clinically effective, … more ➔
ServierVenture CapitalInside Servier’s new €200M venture fundWith the launch of Servier Ventures announced in January and a €200 million commitment to biotech investment, Servier is stepping up its engagement in early-stage innovation in oncology and neurology. … more ➔
CONCEPT HEIDELBERG GmbHPharmaCongressProfessor Wallhäußer Innovation Award 2026The 2026 Professor Wallhäußer Innovation Award was presented during this year’s PharmaCongress & PharmaTechnica 2026 at the end of March. First place went to AstraZeneca for the project “Automated … more ➔
Svitlana Hulko-freepik.comDeep DiveCan biotech finally fix infertility?According to the WHO, one adult in six globally is affected by infertility, but beyond this statistic, infertility is best understood as a couple’s problem, even when the underlying biology … more ➔
www.istockphoto.com/YuriVenture StudiosEurope’s distinct biotech venture studio modelFor decades, biotech companies were formed around a discovery: a promising biological signal, a novel target, a platform emerging from academic research. Now a different formation model is gaining momentum: … more ➔
SLASEventSLAS Announces the Cohort for Innovation AveNEW at SLAS Europe 2026Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, 19-21 May 2026 more ➔
VanessaSpencer - stock.adobe.comBiotech ClusterPortugal’s biotech industry is growing upFor years, Portugal sat just outside Europe’s main biotech conversation: scientifically credible, strong in research, but too small, too fragmented and too thinly financed to compete with the established … more ➔
Kelli McClintock auf UnsplashStartups10 European Startups to watch in 2026Ten young European biotechs are heading into 2026 with the kind of momentum that can quickly turn promising science into defining data: first clinical entries, platform-to-pipeline transitions, and funding … more ➔
CencoraBest PracticeMitigating regulatory risk with holistic CMC strategiesAs advanced therapeutic medicinal products (ATMPs) and other next-generation biologics move toward approval, Chemistry, Manufacturing and Controls (CMC) continues to be the most frequent source of regulatory … more ➔
Boehmert & BoehmertIntellectual PropertyIs the Unified Patent Court affordable for small biotechs?The Unified Patent Court and the unitary patent were established to make patent litigation in Europe easier, faster and more affordable. It has been particularly emphasized that the new system was designed … more ➔
Sevan Habeshian & Christian Heinis et al. https://www.nature.com/articles/s41467-022-31428-
Servier
CONCEPT HEIDELBERG GmbH
Svitlana Hulko-freepik.com
www.istockphoto.com/Yuri
SLAS
VanessaSpencer - stock.adobe.com
Kelli McClintock auf Unsplash
Cencora
Boehmert & Boehmert